ANTI-TNF AGENTS AND VEDOLIZUMAB HAVE SIMILAR SAFETY AS FIRST-LINE BIOLOGIC TREATMENT OF ELDERLY PATIENTS WITH ULCERATIVE COLITIS

Noy Nachmias Peiser  1     Tamar Thurm  1     Nathaniel Aviv Cohen  1     Ayal Hirsch  1     Yulia Ron  1     Nitsan Maharshak  1    
1 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing